Recent Finacing
Recent Raise
Elevation Oncology is a clinical-stage biopharmaceutical company developing therapies for genomically defined cancers, advancing seribantumab (HER3 antibody) in Phase 2 CRESTONE for NRG1 fusions and partnering with NGS providers.
